Clinical Trial Update: Evaluating Tumor Pseudoprogression With FLT-PET and MRI [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 clinical trial evaluating tumor pseudoprogression using FLT-PET and MRI in glioblastoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Glioblastoma | EARLY_Phase 1 | Status: TERMINATED